Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02062879 · ClinicalTrials.gov registry record · Phase 3
Ketamine Patient-Controlled Analgesia for Acute Pain
A Phase 3 study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT02062879: Clinical Trial Phase 3 study, sponsored by University of Cincinnati.
NCT02062879 is a Phase 3 study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 20 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02062879, a Phase 3 study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will compare ketamine and hydromorphone as alternative patient-controlled interventions for trauma-related pain. Patients receiving ketamine PCA are expected to require less total and breakthrough opioid and to have similar or improved objective pain scores. Patients receiving ketamine are also expected to have shorter duration of supplemental oxygen requirement, fewer episodes of oxygen desaturation, improved pulmonary toilet, lower use of antiemetics, and shorter times to first bowel movement. Ketamine is further expected to be associated with decreased intensive care unit and hospital lengths of stay, faster time to maximum allowable ambulation, decreased opioid dosage at discharge, and lower report of chronic pain syndromes.
Primary Outcome
Daily breakthrough opioid requirement plus non-breakthrough opioid use in milligrams of morphine equivalents
Interventions
- DRUG Ketamine
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
Why NCT02062879 stopped before completion
NCT02062879 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02062879 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02062879 about?
NCT02062879 is a clinical study titled "Ketamine Patient-Controlled Analgesia for Acute Pain". This study will compare ketamine and hydromorphone as alternative patient-controlled interventions for trauma-related pain. Patients receiving ketamine PCA are expected to require less total and breakthrough opioid and to have similar or improved objective pain scores. Patients receiving ketamine ar...
What is the current status of trial NCT02062879?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2014-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02062879?
The interventions under investigation include: Ketamine (DRUG), Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT02062879?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02062879's enrollment target sits among peer trials
20 1956th of 2000 higher than 32 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia